Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.594,73
0,61%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Bolt Biotherapeutics Inc (BOLT) Bolt Biotherapeutics Inc (BOLT) Notizie

Bolt Biotherapeutics Inc

BOLT
0,76
-0,0092 (-1,20%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/6/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/6/202400:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202419:15EDGAR2Form 8-K - Current report
20/5/202419:22EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/5/202423:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/5/202422:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:06EDGAR2Form 8-K - Current report
14/5/202422:05GLOBEBolt Biotherapeutics Reports First Quarter 2024 Results,..
21/3/202421:05GLOBEBolt Biotherapeutics Reports Fourth Quarter and Full-Year..
06/3/202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202419:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202413:00GLOBEBolt Biotherapeutics to Present at the TD Cowen 44th Annual..
13/2/202403:41EDGAR2Form SC 13D/A - General statement of acquisition of..
06/2/202419:09EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
21/12/202313:30GLOBEPacira Appoints Frank D. Lee as Chief Executive Officer
13/12/202319:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202313:00GLOBEBolt Biotherapeutics Enrolls First Patient in Phase 2..
09/11/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:08EDGAR2Form 8-K - Current report
09/11/202322:05GLOBEBolt Biotherapeutics Reports Third Quarter 2023 Financial..
07/11/202313:00GLOBEBolt Biotherapeutics to Present at Stifel 2023 Healthcare..
23/10/202316:30GLOBEBolt Biotherapeutics Presents Updated Clinical Data from..
18/10/202313:00GLOBEBolt Biotherapeutics to Present Data at the Society for..
17/10/202313:00GLOBEBolt Biotherapeutics Announces First Patient Dosed in Phase..
16/10/202313:00GLOBEBolt Biotherapeutics to Present New Clinical Data from..
28/9/202313:00GLOBEBolt Biotherapeutics Receives Orphan Drug Designation for..
12/9/202314:05GLOBEBolt Biotherapeutics Announces Issuance of U.S. Patent..
05/9/202322:15GLOBEBolt Biotherapeutics to Participate in September Investor..
07/8/202322:10GLOBEBolt Biotherapeutics Reports Second Quarter 2023 Financial..
07/8/202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202322:06EDGAR2Form 8-K - Current report
03/8/202313:30GLOBEBolt Biotherapeutics Initiates Phase 2 Clinical Studies of..
31/7/202323:27GLOBEBolt Biotherapeutics to Present at BTIG Virtual..
Apertura: 0,77 Min: 0,7501 Max: 0,7774
Chiusura: 0,7692

La tua Cronologia

NASDAQ
BOLT
Bolt Biotherapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network